Accord named company of the year
Executive Summary
Accord Healthcare and its Intas parent company have taken home a total of three prizes at the Global Generics & Biosimilars Awards 2018 that were held on 9 October in Madrid, Spain, by Generics bulletin and co-hosted by Iqvia. Accord Healthcare won the overall Award for Company of the Year as well as the Biosimilar Initiative of the Year Award – for its Pelgraz (pegfilgrastim) biosimilar – while Intas and Accord together won the Award for Company of the Year in the Asia-Pacific region.